z-logo
Premium
NuvaRing: new combined hormonal contraceptive device
Author(s) -
Chaplin Steve,
Peers Tina
Publication year - 2009
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.526
Subject(s) - medicine , etonogestrel , hormonal contraception , ethinylestradiol , adverse effect , gynecology , birth control , obstetrics , family planning , population , pharmacology , research methodology , environmental health
Abstract NuvaRing is a new contraceptive device that delivers ethinylestradiol and etonogestrel and is inserted once every cycle for three weeks. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Tina Peers comments on its place as a birth control option. Copyright © 2009 Wiley Interface Ltd

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here